As per the current valuation of Indian currency, the vaccine would be available for Rs 225 per dose. "And to ensure maximum immunisation coverage and contain the pandemic, it is important to make sure that the most remote and poorest countries of the world have access to affordable cures and preventive measures", said Adar Poonawalla, Chief Executive of the Serum Institute of India.
The Bill and Melinda Gates Foundation, via its Strategic Investment Fund, will provide at-risk funding of United States dollars 150 million to Gavi, which will then be utilized to support the Serum Institute to manufacture the potential vaccine candidate.
Two Australian research teams in Adelaide and at the University of Queensland are already at the clinical trial stage in the development of a COVID-19 vaccine - meaning they are testing their drug on humans. It had already announced plans to make and distribute a billion doses of Oxford's yet-to-be approved coronavirus vaccine.
Serum Institute had in June signed a pact to provide a billion doses of the vaccine, and on Thursday signed a pact with Novovax to produce a minimum of 1 billion doses of its candidate NVX-CoV2373 for India and other low-income countries.
These tie-ups remain as it is, and thereby implying that apart from the commitment of the 100 mn doses supply to Gavi, the company may choose to price it differently in India. The Oxford/AstraZeneca candidate, ChAdOx1 nCoV-19, is now undergoing the late-stage, phase 3 clinical trials in the United Kingdom and Brazil, and phase 1/2 trials in South Africa.
Meanwhile, the Serum Institute of India (SII) has made a big announcement about Corona's vaccine.
It is to be noted that SII's vaccine productions for the 2 candidates shall be procured only if they successful get a "thumbs up", or manages to get the full licensing from WHO.
Director-General of the Indian Council of Medical Research Balram Bhargava said that this partnership is a further step in India's efforts to strengthen the fight against this global pandemic. Once a vaccine or vaccine is authorized by the regulator and authorized by the World Health Organization, it's beneath the Gavi Kovacs AMC by the primary half of 2021 Sufficient doses could be produced for distribution in India and different low-middle-income nations.